A triumvirate is a three-person (or three-group) organization which is established for a specific administrative task(s). In Ancient Rome, the First Triumvirate was established between Julius Caesar, Pompey the…
Ample numbers of electrons will be spent discussing the BIO2016 conference in San Francisco last week, both positive and negative. Not wanting to be left out of the fun,…
Next week, our industry makes an unusual return trip to Union Square, as we return for another conference. This time, it's BIO. BIO is unlike other conferences on our circuit,…
There is an interesting article in the current issue of The Journal of Precision Medicine on Alzheimer's. The article attempts to answer a seemingly simple, yet complex question...Can systems biology…
Our friends at PharmaCircle recently published an interesting and provocative piece entitled Injectables: The New Oral? The PDF is available here. The article notes that, in 2014, seven of the…
How was Bio Europe in Stockholm last week? The Conference Itself – For us, the conference was terrific. We had nearly 30 high-quality meetings over the three days of partnering,…
We're late to the this party, but HBM Partners issued their two annual reports on M&A Activity and New Drug Approvals. Both reports also have Excel files with raw…
At last month's Biotech Showcase, a panel discussion was held discussing different models for advancing assets without resorting to a license. The link to the discussion is here. It…
Nearly 30 years ago, back when your author was a humble pharmacy intern, the first therapeutic to combat HIV (azidothymidine) was introduced by Burroughs Wellcome (now part of GSK). Back…
Given that we are now in January, we feel obliged to craft some sort of "Predictions for 2016" post. We're not big fans of predictive posts, mainly because we're…